Psoriatreat Psoriasis Research And Homeopathic Clinics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.59 Cr
as on 07-12-2024
- Revenue 54.34%
(FY 2017)
- Profit 233.10%
(FY 2017)
- Ebitda 160.28%
(FY 2017)
- Net Worth 202.24%
(FY 2017)
- Total Assets 303.60%
(FY 2017)
About Psoriatreat Psoriasis Research And Homeopathic Clinics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.59 Cr.
Rajendra Sonawane, Ranjana Sonawane, and Ronit Sonawane serve as directors at the Company.
- CIN/LLPIN
U85100PN2012PTC144927
- Company No.
144927
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Psoriatreat Psoriasis Research And Homeopathic Clinics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ronit Sonawane  | Director | 16-Jun-2020 | Current |
| Rajendra Sonawane | Director | 04-Oct-2012 | Current |
| Ranjana Sonawane | Director | 04-Oct-2012 | Current |
Financial Performance of Psoriatreat Psoriasis Research And Homeopathic Clinics.
Psoriatreat Psoriasis Research And Homeopathic Clinics Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 54.34% increase. The company also saw a substantial improvement in profitability, with a 233.1% increase in profit. The company's net worth Soared by an impressive increase of 202.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Psoriatreat Psoriasis Research And Homeopathic Clinics?
In 2017, Psoriatreat Psoriasis Research And Homeopathic Clinics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2022 | ₹1.99 Cr | Open |
Others Creation Date: 08 Jul 2016 | ₹1.60 Cr | Open |
How Many Employees Work at Psoriatreat Psoriasis Research And Homeopathic Clinics?
Unlock and access historical data on people associated with Psoriatreat Psoriasis Research And Homeopathic Clinics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Psoriatreat Psoriasis Research And Homeopathic Clinics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Psoriatreat Psoriasis Research And Homeopathic Clinics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
